Article Details
Retrieved on: 2024-04-09 13:27:46
Tags for this article:
Click the tags to see associated articles and topics
Summary
NICE has recommended Gilead Sciences' antiviral drug remdesivir (Veklury) for treating COVID-19 in vulnerable adults and children in the UK, marking a significant development in COVID-19 drug management and treatment practices.
Article found on: www.pharmiweb.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here